share

(6,11,16)-Trihydroxy-2'-Methyl-5'H-Pregna-1,4-Dieno[17,16-D]Oxazole-3,20-Dione CAS NO 72099-45-7


Unit Price:

CAS No.:72099-45-7

Grade:Pharmacy Grade

Content:99.9%

Brand:Customizable

Packaging:Customizable

Description

(6,11,16)-Trihydroxy-2'-Methyl-5'H-Pregna-1,4-Dieno[17,16-D]Oxazole-3,20-Dione is a high-purity, complex steroid-derived oxazole compound. This specialized intermediate is critical for advanced pharmaceutical research and development, particularly in the synthesis of novel therapeutic agents. It is primarily utilized by research institutions and pharmaceutical manufacturers focused on developing new steroid-based drugs and exploring complex heterocyclic chemistry.

Application

  • Pharmaceutical Intermediate: Key building block in the synthesis of novel steroid-based active pharmaceutical ingredients (APIs).
  • Medicinal Chemistry Research: Used in R&D for structure-activity relationship (SAR) studies and the development of new therapeutic candidates.
  • Steroid Derivative Synthesis: Serves as a precursor for creating modified steroids with potential hormonal or anti-inflammatory activity.
  • Biochemical Research: Employed in studies investigating steroid-receptor interactions and metabolic pathways.
  • Process Development: Used in scaling up synthetic routes for complex heterocyclic compounds in pilot plants.
  • Reference Standard: Can be supplied as a high-purity analytical standard for quality control and method validation.

Basic Information

Product Name (6,11,16)-Trihydroxy-2'-Methyl-5'H-Pregna-1,4-Dieno[17,16-D]Oxazole-3,20-Dione
CAS No. 72099-45-7
Molecular Formula C24H29NO6
Molecular Weight 427.49 g/mol
Synonyms Pregna-1,4-dieno[17,16-d]oxazole-3,20-dione, 6,11,16-trihydroxy-2'-methyl-5'H-; 2'-Methyl-5'H-pregna-1,4-dieno[17,16-d]oxazole-3,20-dione, 6,11,16-trihydroxy-; 72099-45-7; (6β,11α,16α)-Trihydroxy-2'-methyl-5'H-pregna-1,4-dieno[17,16-d]oxazole-3,20-dione; Steroid Oxazole Derivative
EINECS Contact for details

Quality Control

Our (6,11,16)-Trihydroxy-2'-Methyl-5'H-Pregna-1,4-Dieno[17,16-D]Oxazole-3,20-Dione is manufactured under strict quality management systems. Each batch undergoes comprehensive analytical testing, including HPLC for purity and identity confirmation via spectroscopic methods, to ensure it meets the stringent requirements for pharmaceutical research. Certificates of Analysis (COA) detailing all specifications are available upon request.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry place at controlled room temperature (15-25°C). Due to its hygroscopic (moisture-sensitive) nature, the container must be kept tightly sealed in a dry environment to prevent degradation. For long-term storage, consider desiccants or inert atmosphere.

Specification

Item Specification
Appearance White to off-white powder
Identification (IR) Conforms to structure
Identification (HPLC) Retention time matches reference standard
Assay (HPLC) ≥ 98.0%
Related Substances (HPLC) Total impurities ≤ 2.0%
Single Maximum Impurity ≤ 0.5%
Water Content (KF) ≤ 1.0%
Residue on Ignition ≤ 0.1%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.

Complete Your RFQ

0/ 2000

why choose us

Trusted Manufacturer

With our own production facilities, we ensure consistent quality, reliable supply, and full traceability.

Rigorous Quality Assurance

Each batch undergoes strict QC, accompanied by COA, MSDS, and full compliance with international standards.

Advanced R&D Expertise

Our in-house lab drives process innovation, new product development, and tailored synthesis solutions.